The goal of this clinical trial is to learn if the newly designed group self-management program is feasible to conduct and improves mental and behavioral health outcomes compared to a control group in people diagnosed with brain cancer. The main questions it aims to answer are:
* Is it feasible to conduct this program? * Does the new group self-management program improve behavioral health outcomes more than in the control group that will not be in a group setting?
Currently living in the United States
Aged 18 years or older
Confirmed diagnosis of a malignant brain tumor including diffuse gliomas, World Health Organization (WHO) grades II, III, and IV (either by directly sharing their pathology report or confirmation from their prescribing treating provider)
Treating prescribing provider who follows regularly with participant
<1 month since initial diagnosis and/or <1 month since surgical resection
Enrollment in hospice
Significant physical or cognitive disabilities that prohibit involvement using our clinician's judgement as a self-management expert, with consultation with personal clinician if needed
Currently receiving psychiatric treatment for a serious mental illness (e.g., schizophrenia)
University of Colorado, Denver
Lead sponsor
University Hospitals Cleveland Medical Center
Collaborator
U.S. Army Medical Research and Development Command
Collaborator
Case Western Reserve University
Collaborator